Suppr超能文献

[维拉帕米抑制DNA的体外合成。I. 人淋巴细胞培养研究]

[Verapamil inhibits the in vitro synthesis of DNA. I. Study of human lymphocyte cultures].

作者信息

Cesano L, Vietti Ramus G, Tartaglino B, Barbalonga A

出版信息

Minerva Med. 1985 Sep 15;76(34-35):1541-8.

PMID:4034053
Abstract

Verapamil in vitro reduced 3H-TdR incorporation into lymphocytes. High doses of Verapamil were lethal for cells; low doses inhibit DNA synthesis, but cell viability by the Trypan blue exclusion method is preserved. Increasing the concentration of Ca++ in the medium partially improved lymphocyte viability and 3H-TdR incorporation. Modification of the Na+ and K+ content in the medium did not interfere with Verapamil action. The inhibitory action was not completely reversible even when the cells were exposed to the drug for a short time (15'). Our results confirm the dependency of lymphocyte blast transformation on Ca++ during the first 20 h. Nifedipine did not inhibit cell replication, which suggests a different mechanism of action. Our investigation suggests that there is more than one model for calcium-antagonism and that the action of Verapamil can not be explained only by its influence on transmembrane Ca++ flux. We believe that Verapamil has a negative action on cell metabolism directly through an interaction on transmembrane Ca++ flux and on intracellular Ca++.

摘要

维拉帕米在体外可减少3H-胸苷掺入淋巴细胞。高剂量的维拉帕米对细胞具有致死性;低剂量则抑制DNA合成,但通过台盼蓝排斥法检测细胞活力得以保留。增加培养基中Ca++的浓度可部分改善淋巴细胞活力及3H-胸苷掺入情况。改变培养基中Na+和K+的含量并不干扰维拉帕米的作用。即使细胞短时间(15分钟)暴露于该药物,其抑制作用也并非完全可逆。我们的结果证实了在最初20小时内淋巴细胞增殖转化对Ca++的依赖性。硝苯地平并不抑制细胞复制,这提示了其不同的作用机制。我们的研究表明,钙拮抗作用存在不止一种模式,且维拉帕米的作用不能仅通过其对跨膜Ca++通量的影响来解释。我们认为,维拉帕米通过与跨膜Ca++通量及细胞内Ca++相互作用,直接对细胞代谢产生负面作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验